China Health Group Inc. (HKG:8225)
0.1430
-0.0040 (-2.72%)
Jan 28, 2026, 6:11 PM HKT
China Health Group Revenue
China Health Group had revenue of 21.62M CNY in the half year ending June 30, 2025, with 43.89% growth. This brings the company's revenue in the last twelve months to 29.78M, up 20.61% year-over-year. In the year 2024, China Health Group had annual revenue of 26.45M with 23.47% growth.
Revenue (ttm)
29.78M CNY
Revenue Growth
+20.61%
P/S Ratio
4.39
Revenue / Employee
676.84K CNY
Employees
44
Market Cap
143.33M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.45M | 5.03M | 23.47% |
| Dec 31, 2023 | 21.43M | 8.34M | 63.67% |
| Dec 31, 2022 | 13.09M | -70.51M | -84.34% |
| Dec 31, 2021 | 83.60M | 538.00K | 0.65% |
| Dec 31, 2020 | 83.06M | 19.85M | 31.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 5.58B |
| Adicon Holdings | 2.98B |
| Kindstar Globalgene Technology | 998.42M |
| Yunkang Group | 706.95M |
| Biosino Bio-Technology and Science Incorporation | 246.61M |
| Mega Genomics | 174.76M |
| Guanze Medical Information Industry (Holding) | 161.70M |
| King International Investment | 77.50M |